Cargando…

The effectiveness and safety of corticosteroid therapy for IgA nephropathy with crescents: a prospective, randomized, controlled study

BACKGROUND: Pozzi protocol (methylprednisolone intravenous infusion in 1st-3rd-5th months and oral steroid for 6 months) has been thought to be the classic therapy for IgA nephropathy (IgAN) patients with proteinuria> 1.0 g/24 h. There is no consensus on the treatments for IgAN with active pathol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Mengjun, Xiong, Liping, Li, Aihua, Zhou, Jiafan, Huang, Yajuan, Huang, Miaofang, Zhang, Xing, Shi, Hongrui, Su, Ning, Wei, Yi, Jiang, Zongpei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780312/ https://www.ncbi.nlm.nih.gov/pubmed/35062886 http://dx.doi.org/10.1186/s12882-022-02661-6

Ejemplares similares

Complement Activation Is Associated With Crescents in IgA Nephropathy
por: Wang, Zi, et al.
Publicado: (2021)

Crescents and IgA Nephropathy: A Delicate Marriage
por: Trimarchi, Hernán, et al.
Publicado: (2022)

TWEAK/Fn14 system and crescent formation in IgA nephropathy
por: Sasaki, Yohei, et al.
Publicado: (2015)

Use of eculizumab in crescentic IgA nephropathy: proof of principle and conundrum?
por: Ring, Troels, et al.
Publicado: (2015)

Clinical outcomes of IgA nephropathy patients with different proportions of crescents
por: Zhang, Wang, et al.
Publicado: (2017)

Retrospective analysis of crescent score in clinical prognosis of IgA nephropathy
por: Chen, Ying, et al.
Publicado: (2022)

A validation study of crescents in predicting ESRD in patients with IgA nephropathy
por: Zhang, Xiaoyan, et al.
Publicado: (2018)

A novel clinical−radiomic nomogram for the crescent status in IgA nephropathy
por: Qin, Xiachuan, et al.
Publicado: (2023)

Crescents proportions above 10% are associated with unfavorable kidney outcomes in IgA nephropathy patients with partial crescent formation
por: Di, Dingxin, et al.
Publicado: (2023)

De-Novo Focal Crescentic IgA Nephropathy in a Renal Allograft Recipient
por: Ramasamy, Ashok, et al.
Publicado: (2019)

Nomogram for the prediction of crescent formation in IgA nephropathy patients: a retrospective study
por: Lin, Zaoqiang, et al.
Publicado: (2023)

Comparative analysis between the safety and efficacy of oral corticosteroids versus corticosteroids pulse therapies in IgA nephropathy
por: Wang, Yu, et al.
Publicado: (2023)

Clinical efficacy and safety of full-dose versus half-dose corticosteroids plus leflunomide for IgA nephropathy
por: Li, Yebei, et al.
Publicado: (2021)

Crescents in IgA nephropathy: making the step from prognostic risk factor to therapy target
por: Stefan, Gabriel
Publicado: (2023)

The Diagnostic Conundrum of Glomerular Crescents With IgA Deposits
por: Kitamura, Mineaki, et al.
Publicado: (2022)

Albumin-to-fibrinogen ratio is an independent predictor of corticosteroid response and prognosis in patients with IgA nephropathy
por: Zhang, Yu, et al.
Publicado: (2023)

New-onset crescent IgA nephropathy following the CoronaVac vaccine: A case report
por: Ran, Enrong, et al.
Publicado: (2022)

The Presence of ANCA in IgA Crescentic Nephropathy Does Not Lead to Worse Prognosis with Intensive Rescue Treatment
por: Agraz, Irene, et al.
Publicado: (2022)

Corticosteroids in Patients with IgA Nephropathy and Severe Chronic Renal Damage
por: Pozzi, Claudio, et al.
Publicado: (2012)

Complete remission of nephrotic syndrome and acute kidney injury in crescentic IgA nephropathy: Role of mycophenolate sodium
por: Bhandari, D., et al.
Publicado: (2016)

Coexistence of atypical hemolytic uremic syndrome and crescentic IgA nephropathy treated with eculizumab: a case report
por: Matsumura, Daisuke, et al.
Publicado: (2016)

Crescent IgA Nephropathy and its association with anti-neutrophil cytoplasm antibody: what do we know?
por: Zamoner, Welder, et al.
Publicado: (2022)

Successful treatment of nephrotic syndrome due to pregnancy-related crescentic IgA nephropathy: a case report
por: Shima, Hisato, et al.
Publicado: (2023)

Corticosteroid Treatment Influences TA-Proteinuria and Renal Survival in IgA Nephropathy
por: Sarcina, Cristina, et al.
Publicado: (2016)

Severe Adverse Effects Associated With Corticosteroid Treatment in Patients With IgA Nephropathy
por: Cai, Qingqing, et al.
Publicado: (2017)

Immunosuppressants or corticosteroids compared with supportive therapy: a systematic review and meta-analysis on the efficacy and safety for IgA nephropathy treatment
por: Feng, Qipu, et al.
Publicado: (2022)

The Role of IgA in the Pathogenesis of IgA Nephropathy
por: Perše, Martina, et al.
Publicado: (2019)

The predictive value and response to immunosuppressive therapy of IgA nephropathy patients with crescents in a large retrospective Chinese cohort
por: Guo, Yingman, et al.
Publicado: (2023)

The effectiveness and safety of full-dose versus half-dose corticosteroid plus renin-angiotensin system blockers for IgA nephropathy
por: Wang, Li, et al.
Publicado: (2019)

Crescentic Glomerulonephritis in IgA Multiple Myeloma: A Case Report
por: Moscoso-Solorzano, Grace T., et al.
Publicado: (2011)

Efficacy and safety of Telitacicept in patients with IgA nephropathy
por: Liang, Dongrui, et al.
Publicado: (2023)

Validation of the revised Oxford classification for IgA nephropathy considering treatment with corticosteroids/immunosuppressors
por: Moriyama, Takahito, et al.
Publicado: (2020)

IgA Vasculitis and IgA Nephropathy: Same Disease?
por: Pillebout, Evangeline
Publicado: (2021)

Associations of corticosteroid therapy and tonsillectomy with kidney survival in a multicenter prospective study for IgA nephropathy
por: Kawamura, Tetsuya, et al.
Publicado: (2023)

High-frequency plasma exchange therapy for immunocompromised, type I crescentic glomerulonephritis complicated with IgA nephropathy: A case report and literature review
por: Chen, Huihui, et al.
Publicado: (2023)

Safety Evaluation of COVID-19 Vaccine in Patients With IgA Nephropathy or IgA Vasculitis Nephritis
por: Zan, Jincan, et al.
Publicado: (2022)

Efficacy and safety of leflunomide combined with corticosteroids for the treatment of IgA nephropathy: a Meta-analysis of randomized controlled trials
por: Lv, Guangxin, et al.
Publicado: (2022)

Experimental IgA nephropathy
Publicado: (1979)

Sulodexide in IgA nephropathy
Publicado: (2013)

T lymphocytes in IgA nephropathy
por: Tang, Yuyan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ftk8v2rd8l4im3331psk85stnk